The Food and Drug Administration approved the first gene therapy to treat the most common form of muscular dystrophy. Sarah Silbiger/Getty Images…
muscular dystrophy
-
-
Enlarge this image In a close vote, advisers to the Food and Drug Administration recommended approval of a gene therapy for muscular…
-
Enlarge this image Susan and Chris Finazzo have enrolled their sons Dylan and Chase in a study of gene therapy for Duchenne…
-
Enlarge this image The list price for a year’s treatment with Emflaza is $89,000. The drug is available outside the U.S. for…
-
Feb. 10, 2017 — A new drug to treat Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration.…
-
Enlarge this image Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the…
-
Enlarge this image Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics…
-
CancerConditionsHeartMedical DictionaryMedicationsMenopausePPregnancyZ
PharmAssure Vitamin E (see Vitamin E (By mouth))
Vitamin E (By mouth) VYE-ta-min E Treats patients who do not have enough vitamin E in the body and may be used…
